MDGL — Madrigal Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- $10.62bn
- $10.13bn
- $958.40m
Madrigal Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Madrigal Pharmaceuticals Q2 revenue rises 71% on Rezdiffra demand
U.S. RESEARCH ROUNDUP-Boeing, Coca-Cola, PayPal
Brief: Madrigal Pharmaceuticals Announces Grants Of Inducement Awards Under Nasdaq Listing Rule 5635(C)(4)
Suzhou Ribo jumps on first milestone achievement from Madrigal tie-up
Brief: Madrigal Pharmaceuticals Announces Grants Of Inducement Awards Under Nasdaq Listing Rule 5635(C)(4)
U.S. STOCKS ON THE MOVE -Fervo, Sensata Technologies, Akamai
U.S. STOCKS ON THE MOVE-Chipmakers, Dynatrace, Alibaba
U.S. STOCKS ON THE MOVE-Nebius, US chipmakers, Assertio Holdings
Truist raises PT on Madrigal Pharma on liver disease drug opportunity
U.S. STOCKS ON THE MOVE-Instacart, New York Times, Novavax
U.S. STOCKS ON THE MOVE-DaVita, Knight-Swift, Madrigal Pharma
Madrigal's Q1 product revenue jumps 127%, net loss widens on higher costs
Brief: Madrigal Pharmaceuticals Inc - Announces Exclusive Global License For Aro-Pnpla3 From Arrowhead
U.S. STOCKS ON THE MOVE-Omnicom, Klarna, US airlines
U.S. STOCKS ON THE MOVE- Etsy, Helmerich and Payne, Integer Holdings
Madrigal Pharmaceuticals down after wider-than-expected Q4 net loss
Madrigal Pharmaceuticals Q4 revenue rises sharply on Rezdiffra sales
Brief: Madrigal Pharmaceuticals Q4 EPS USD -2.57